
Granisev 3ml Injection
Price: 1 USD
Get Latest Price
Minimum Order Quantity :
25
In Stock
Product Specifications
| Properties | Granisetron is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.from MeSHGranisetron is a Serotonin-3 Receptor Antagonist. The mechanism of action of granisetron is as a Serotonin 3 Receptor Antagonist.FDA Pharmacology Summary from FDA Pharm ClassesGranisetron is an indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-hydroxytryptamine3 (5-HT3) receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting. |
| HS Code | 29339900 |
| Physical Form | Powder |
| Ingredients | GRANISERTON |
| Product Type | GRANISETRON |
| FOB Port | jnpt |
| Payment Terms | Cash on Delivery (COD), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Cash Against Delivery (CAD), Telegraphic Transfer (T/T) |
| Supply Ability | 2000 vial Per Week |
| Delivery Time | 2 Week |
| Sample Available | Yes |
| Sample Policy | Contact us for information regarding our sample policy |
| Packaging Details | NORMAL |
| Main Export Market(s) | Western Europe, Africa, Central America, Middle East, South America, Asia, Eastern Europe, North America, Australia |
| Main Domestic Market | All India |
| Certifications | ISO |
Product Overview
Key Features
Granisetron is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.
from MeSH
Granisetron is a Serotonin-3 Receptor Antagonist. The mechanism of action of granisetron is as a Serotonin 3 Receptor Antagonist.
FDA Pharmacology Summary from FDA Pharm Classes
Granisetron is an indazole derivative with antiemetic properties. As a selective serotonin receptor antagonist, granisetron competitively blocks the action of serotonin at 5-hydroxytryptamine3 (5-HT3) receptors, resulting in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.
Company Details
Neetco biopharma Pvt. Ltd. is a privately owned, pharmaceutical company with headquarters in pune, India. An Indian pharmaceutical company oncology (anti-cancer) drugs, driven to expand the boundaries of science to improve human health. A company with first-in-class therapeutics, a rich oncology product pipeline, medications to treat cancer and other chronic diseases. A company dedicated to our patients, healthcare professionals, employees, and communities. The company has built a flexible business model around partnering to grow its manufacturing, R&D pipeline, its product portfolio, and extend its geographical reach.
Business Type
Exporter, Distributor, Supplier, Trading Company
Employee Count
10
Establishment
2013
Working Days
Monday To Sunday
GST NO
27AJDPC5511A1Z1
Related Products
More Product From This seller
Seller Details
GST - 27AJDPC5511A1Z1
Pune, Maharashtra
Accepts only Domestic inquiries
Proprietor
Mr Amit S. Chaure
Members since
1 Years
Address
Shop No. 2, Ground floor, Sr. No-51 Plot No -197, Subham Apartment, Bhairav Nagar, Dhanori, Pune, Maharashtra, 411015, India
Report incorrect details
























